• Home
  •  / Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings

OverviewSuggest Edit

Laboratory Corporation of America Holdings (LabCorp) is a life sciences company that provides comprehensive clinical laboratory and end-to-end drug development services. It operates through LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) segments. The company offers a range of clinical laboratory tests used by hospitals, physicians, and other healthcare providers and commercial clients to assist in the diagnosis, monitoring, and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. LabCorp also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, medical drug monitoring, and pain management, as well as esoteric testing, cancer diagnostics, and other complex procedures. Through the CDD segment, the company provides drug, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access.

TypePublic
Founded1976
HQBurlington, NC, USMap
Websitelabcorp.com
Overall CultureBMore
View Jobs (12)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)65,000(+7%)
Job Openings12
Revenue (FY, 2020)$14 B(+21%)
Share Price (Mar 2021)$241.5
Cybersecurity ratingAMore

Key People/Management at Laboratory Corporation of America Holdings

Adam H. Schechter

Adam H. Schechter

President and Chief Executive Officer
David P. King

David P. King

Executive Chairman of the Board, Director
Glenn A. Eisenberg

Glenn A. Eisenberg

Executive Vice President and Chief Financial Officer
Lance V. Berberian

Lance V. Berberian

Executive Vice President, Chief Information and Technology Officer
Peter J. Wilkinson

Peter J. Wilkinson

Senior Vice President and Chief Accounting Officer
Kerrii B. Anderson

Kerrii B. Anderson

Director
Show more

Laboratory Corporation of America Holdings Office Locations

Laboratory Corporation of America Holdings has an office in Burlington
Burlington, NC, US (HQ)
531 S Spring St
Show all (1)

Laboratory Corporation of America Holdings Financials and Metrics

Laboratory Corporation of America Holdings Revenue

Embed Graph
View revenue for all periods
Laboratory Corporation of America Holdings's revenue was reported to be $13.98 b in FY, 2020
USD

Revenue (FY, 2020)

14.0b

Gross profit (FY, 2020)

5.0b

Gross profit margin (FY, 2020), %

35.4%

Net income (FY, 2020)

1.6b

EBIT (FY, 2020)

2.4b

Market capitalization (1-Mar-2021)

23.5b

Closing stock price (1-Mar-2021)

241.5

Cash (31-Dec-2020)

1.3b

EV

22.7b
Laboratory Corporation of America Holdings's current market capitalization is $23.5 b.
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

5.0b5.5b5.7b5.8b6.0b8.5b9.4b10.2b11.3b11.6b14.0b

Revenue growth, %

4%44%11%

Cost of goods sold

2.9b3.3b3.4b3.6b3.8b5.6b6.3b6.7b8.2b8.3b9.0b

Gross profit

2.1b2.3b2.2b2.2b2.2b2.9b3.2b3.5b3.2b3.3b5.0b
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

1.2b1.2b1.3b1.4b1.4b1.4b1.4b1.4b1.4b1.4b1.5b1.5b1.4b1.5b1.6b1.8b2.2b2.3b2.3b2.4b2.4b2.4b2.5b2.6b2.8b2.9b2.8b2.8b2.9b2.9b2.8b2.8b3.9b

Cost of goods sold

686.7m704.8m748.8m800.0m815.1m836.0m847.2m843.9m863.3m868.7m890.9m914.6m913.9m947.8m980.6m1.2b1.4b1.5b1.5b1.6b1.6b1.6b1.6b1.7b2.1b2.0b2.0b2.0b2.1b2.1b2.1b2.0b2.3b

Gross profit

506.9m533.6m527.7m568.4m588.2m568.5m576.1m579.5m556.1m572.2m577.3m547.6m516.8m568.6m571.2m596.0m774.6m762.9m777.3m826.8m788.4m803.6m861.8m882.8m779.0m835.1m789.9m789.7m824.8m817.3m728.0m760.5m1.6b

Gross profit Margin, %

42%43%41%42%42%40%40%41%39%40%39%37%36%37%37%34%35%34%34%35%33%33%34%34%27%29%28%28%29%28%26%27%40%
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

230.7m159.3m466.8m404.0m580.0m716.4m433.6m316.7m426.8m337.5m1.3b

Accounts Receivable

655.6m699.8m718.5m784.7m815.7m1.2b1.3b1.5b1.5b1.5b2.5b

Prepaid Expenses

95.7m79.6m74.6m157.5m340.3m321.2m421.4m309.0m373.7m364.8m

Inventories

103.4m110.8m121.0m136.5m139.5m191.0m205.2m227.6m237.3m244.7m423.2m
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

172.2m103.8m96.9m195.4m118.9m85.8m129.9m124.4m466.0m185.8m111.3m174.1m338.9m479.5m575.7m446.4m619.0m713.0m696.3m639.6m567.6m365.5m299.9m409.3m361.8m221.4m892.6m348.8m265.4m361.1m323.6m667.2m

Accounts Receivable

614.3m617.6m631.0m717.3m714.8m718.7m751.7m735.8m768.9m793.8m815.7m813.2m822.0m832.6m841.6m1.2b1.2b1.2b1.3b1.3b1.3b1.4b1.4b1.6b1.6b1.5b1.5b1.6b1.6b1.6b1.5b

Prepaid Expenses

74.3m69.0m68.7m71.8m64.4m78.4m69.8m68.1m78.2m67.4m75.3m79.9m125.2m115.2m126.3m319.8m387.3m378.3m360.1m297.2m325.6m343.1m379.3m450.2m347.0m286.1m292.5m317.1m298.6m297.7m353.2m317.5m327.2m

Inventories

82.5m86.3m88.2m98.0m106.8m103.8m107.0m114.0m118.9m124.0m126.4m126.5m134.8m134.5m138.8m186.5m182.0m181.6m188.2m189.6m198.8m199.8m209.9m217.2m226.2m230.7m233.0m233.7m219.7m234.9m342.3m392.5m
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

558.2m519.7m583.1m575.4m512.6m438.0m733.2m1.3b883.9m824.9m

Depreciation and Amortization

203.6m231.4m229.8m245.5m457.8m499.2m552.1m577.2m624.7m

Inventories

5.8m(6.1m)(6.3m)(15.3m)(300.0k)(200.0k)(9.6m)(16.4m)(18.9m)(21.9m)(196.6m)

Accounts Payable

50.1m(8.7m)(30.0m)60.8m(21.2m)30.7m(8.7m)85.6m43.3m(12.8m)(5.3m)
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

136.2m286.4m426.4m127.1m250.0m384.3m161.6m314.9m462.9m147.2m299.2m448.7m113.5m255.2m392.7m1.0m170.3m323.5m160.2m359.0m548.6m192.5m381.4m564.8m172.5m406.6m725.7m185.9m376.6m597.6m(316.9m)

Depreciation and Amortization

50.0m100.1m150.7m58.1m115.9m173.6m56.7m112.8m170.4m55.5m112.4m170.3m60.7m123.5m182.0m104.7m223.1m344.5m122.4m247.8m368.9m128.1m255.1m388.2m142.8m281.3m414.4m137.3m277.1m421.4m144.6m

Inventories

(7.7m)(3.8m)(2.3m)(5.6m)2.7m(900.0k)3.9m(3.3m)(4.3m)(3.2m)(5.7m)(5.6m)2.9m3.4m(1.3m)4.2m9.5m9.6m2.4m600.0k(4.8m)4.9m(700.0k)(6.4m)1.4m(4.7m)(8.8m)3.4m(1.7m)(14.5m)(10.6m)

Accounts Payable

(14.8m)9.1m(8.9m)(42.6m)(57.3m)(40.8m)(32.3m)(23.3m)(19.4m)10.1m16.9m25.2m(27.1m)(25.7m)(16.2m)(48.9m)(33.8m)(24.3m)(34.1m)(54.3m)(56.3m)(28.0m)(29.0m)29.6m(59.8m)(91.3m)(79.9m)(28.8m)(28.2m)(56.5m)
show all
USDQ1, 2010

Financial Leverage

2.3 x
Show all financial metrics

Laboratory Corporation of America Holdings Operating Metrics

FY, 2016

Countries

60

Patient Service Centers

1.75 k
Show all operating metrics

Laboratory Corporation of America Holdings Revenue Breakdown

Embed Graph

Laboratory Corporation of America Holdings revenue breakdown by business segment: 69.9% from LCD and 30.1% from CDD

Laboratory Corporation of America Holdings Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

Learn more about our premium products
SecurityScorecard logo

Laboratory Corporation of America Holdings Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

Learn more about our premium products
CSRHub logo

Laboratory Corporation of America Holdings Online and Social Media Presence

Laboratory Corporation of America Holdings's Trends

Embed Graph

Laboratory Corporation of America Holdings Company Culture

  • Overall Culture

    B

    78/100

  • CEO Rating

    D+

    65/100

  • Compensation

    D

    55/100

Learn more on Comparably

Laboratory Corporation of America Holdings News and Updates

June 06, 2019

Faruqi & Faruqi, LLP is Investigating Laboratory Corporation of America Holdings (LH) on Behalf of its Shareholders

NEW YORK, June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Laboratory Corporation of America Holdings ("LabCorp" or the "Company") (NYSE:LH). The investigation focuses on whether the Company's Board of...
January 11, 2019

New Study Focusing on Healthcare Contract Research Outsourcing Market by 2023: Competition Status, Emerging Trends, Growth Factors and Key Players Like IQVIA, PRA Health Sciences, Inc., ICON PLC, and Laboratory Corporation of America Holdings, PAREXEL Int

The Healthcare Contract Research Outsourcing Market report provides complete insights of the market by segmenting the market. Posted via Industry Today. Follow us on Twitter @IndustryToday
November 27, 2018

Global Esoteric Testing Market Analysis and Forecasts Report 2018-2025 Featuring Key Players - Laboratory Corporation of America Holdings & Quest Diagnostics Incorporated

DUBLIN, Nov. 27, 2018 /PRNewswire/ -- The "Esoteric Testing Market to 2025 - Global Analysis and Forecasts by Technology, Test Type, End User and Geography" report has been added to ResearchAndMarkets.com's offering. The market is expected to reach US$ $ 45,081.6 Mn in 2025 from US$...

Laboratory Corporation of America Holdings Blogs

March 04, 2021

Presage Sets the Stage for Commercial Expansion with $13M Financing and New Phase 0 Trial Agreements with Merck and Maverick Therapeutics

Presage Sets the Stage for Commercial Expansion with $13M Financing and New Phase 0 Trial Agreements with Merck and Maverick Therapeutics roigr Thu, 03/04/2021 - 13:31 Funds Will Support Expansion of Comparative In Vivo Oncology (CIVO®) Technology…
March 04, 2021

TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round

TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round dionc1 Thu, 03/04/2021 - 13:14 Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy indu…
March 02, 2021

Labcorp COVID-19 Update: Innovations in Testing and Vaccine Distribution

Labcorp COVID-19 Update: Innovations in Testing and Vaccine Distribution dionc1 Tue, 03/02/2021 - 09:16 WebinarsHost: Amy Tenny Speakers: Dorothy M Adcock, MD Heather Provino, MS Length: 56:50 https://vimeo.com/518593522/6214f14fe902/25/2021
February 25, 2021

Celiac Disease Foundation Advocates Urge Congress To Continue Support of Celiac Disease Research Funding

Celiac Disease Foundation Advocates Urge Congress To Continue Support of Celiac Disease Research Funding dionc1 Thu, 02/25/2021 - 08:32 LOS ANGELES – (February 18, 2021) – Celiac disease afflicts millions of Americans, most of whom are undiagnosed, …
February 24, 2021

Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide

Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide dionc1 Wed, 02/24/2021 - 13:50 Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Cou…
February 23, 2021

Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference

Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference John.Bissaillo… Tue, 02/23/2021 - 06:54 Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Feb 23, 202…
Show more

 Laboratory Corporation of America Holdings Frequently Asked Questions

  • When was Laboratory Corporation of America Holdings founded?

    Laboratory Corporation of America Holdings was founded in 1976.

  • Who are Laboratory Corporation of America Holdings key executives?

    Laboratory Corporation of America Holdings's key executives are Adam H. Schechter, David P. King and Glenn A. Eisenberg.

  • How many employees does Laboratory Corporation of America Holdings have?

    Laboratory Corporation of America Holdings has 65,000 employees.

  • What is Laboratory Corporation of America Holdings revenue?

    Latest Laboratory Corporation of America Holdings annual revenue is $14 b.

  • What is Laboratory Corporation of America Holdings revenue per employee?

    Latest Laboratory Corporation of America Holdings revenue per employee is $215.1 k.

  • Who are Laboratory Corporation of America Holdings competitors?

    Competitors of Laboratory Corporation of America Holdings include SYNLAB International, NeoGenomics Laboratories and LifeLabs.

  • Where is Laboratory Corporation of America Holdings headquarters?

    Laboratory Corporation of America Holdings headquarters is located at 531 S Spring St, Burlington.

  • Where are Laboratory Corporation of America Holdings offices?

    Laboratory Corporation of America Holdings has an office in Burlington.

  • How many offices does Laboratory Corporation of America Holdings have?

    Laboratory Corporation of America Holdings has 1 office.